Codeine Phosphate and Guaifenesin and Sodium oxybate
Determining the interaction of Codeine Phosphate and Guaifenesin and Sodium oxybate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: The central nervous system and respiratory depressant effects of sodium oxybate, which is the sodium salt of gamma hydroxybutyrate (GHB), may be potentiated by concomitant use of other agents with CNS depressant effects. An increased risk of serious adverse reactions such as respiratory depression, hypotension, profound sedation, syncope, coma, and even death should be considered. MANAGEMENT: Concomitant use of sodium oxybate with other CNS depressants should be avoided whenever possible. Otherwise, close monitoring and/or dosage reductions should be considered. If short-term use of a CNS depressant is required (e.g., post- or perioperative opioid), a temporary interruption of sodium oxybate therapy may be appropriate. All patients treated with sodium oxybate should be advised not to drive, operate machinery, or engage in hazardous activities requiring mental alertness and motor coordination for at least 6 hours after taking the second nightly dose of sodium oxybate and until they know how the medication affects them. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Xyrem (sodium oxybate)." Orphan Medical, Minnetonka, MN.
Professional:GENERALLY AVOID: The central nervous system and respiratory depressant effects of sodium oxybate, which is the sodium salt of gamma hydroxybutyrate (GHB), may be potentiated by concomitant use of other agents with CNS depressant effects. An increased risk of serious adverse reactions such as respiratory depression, hypotension, profound sedation, syncope, coma, and even death should be considered.
MANAGEMENT: Concomitant use of sodium oxybate with other CNS depressants should be avoided whenever possible. Otherwise, close monitoring and/or dosage reductions should be considered. If short-term use of a CNS depressant is required (e.g., post- or perioperative opioid), a temporary interruption of sodium oxybate therapy may be appropriate. All patients treated with sodium oxybate should be advised not to drive, operate machinery, or engage in hazardous activities requiring mental alertness and motor coordination for at least 6 hours after taking the second nightly dose of sodium oxybate and until they know how the medication affects them.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Xyrem (sodium oxybate)." Orphan Medical, Minnetonka, MN.
Generic Name: codeine / guaifenesin
Brand name: Allfen CD, Cheracol with Codeine, Cheratussin AC, Codar GF, Duraganidin NR, Guaiatussin AC, Iophen-C NR, Mar-cof CG, M-Clear, Mytussin AC, Relcof C, Guaifenesin AC Liquid, Iophen C-NR, Mar-cof CG, Ninjacof-XG, Virtussin A/C
Synonyms: Codeine and guaifenesin, Guaifenesin and Codeine
Generic Name: sodium oxybate
Brand name: Xyrem
Synonyms: Sodium Oxybate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Codeine Phosphate and Guaifenesin-Sodium phenylacetate and benzoate Intravenous
- Codeine Phosphate and Guaifenesin-Sodium Phenylacetate and Sodium Benzoate
- Codeine Phosphate and Guaifenesin-Sodium Phenylacetate and Sodium Benzoate Injection
- Codeine Phosphate and Guaifenesin-Sodium phenylbutyrate
- Codeine Phosphate and Guaifenesin-Sodium Phenylbutyrate Powder
- Codeine Phosphate and Guaifenesin-Sodium Phenylbutyrate Tablets
- Sodium oxybate-Codeine Phosphate-Promethazine HCl
- Sodium oxybate-Codeine Sulfate
- Sodium oxybate-Codeine Sulfate Oral Solution
- Sodium oxybate-Codeine Tablets
- Sodium oxybate-Codeine, Dexbrompheniramine, and Pseudoephedrine Liquid
- Sodium oxybate-Codeine, guaifenesin, and pseudoephedrine